Literature DB >> 18019343

Improved agarose gel assay for quantification of growth factor-induced cell motility.

Yoanne Mousseau1, Dany Leclers, Karine Faucher-Durand, Jeanne Cook-Moreau, Anne-Sophie Lia-Baldini, Michel Rigaud, Franck G Sturtz.   

Abstract

Cell chemotaxis is frequently required in normal or pathological situations such as invasion, metastasis, and tumor angiogenesis and may involve many different cell types. At present, no device can simultaneously (i) make morphological observations, (ii) quantify cell migration, (iii) test multiple chemoattracting gradients, and (iv) analyze cell-cell interactions. We developed an agarose-based assay to address these questions. Two glass molds were designed, around which agarose gel could be poured to form specific well shapes. Using a vital nuclear stain (Hoechst 33258), we characterized the migration profile of adherent or suspension cells. Cells could be observed during the entire migration process. We were able to follow cells moving toward chemoattractants or being repulsed by other molecules, and we could estimate average migration speed. Using this inexpensive assay, we were able to obtain precise, reproducible results concerning the chemotactic behavior of different cell types. The resulting data differentiated between chemokinetic and chemotactic movement. Chemotactic potencies could be compared using different criteria, such as the number of attracted cells, induced speed, and morphological aspect. This improved agarose assay appears to be a reliable and inexpensive alternative to other available chemotaxis study tools.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18019343     DOI: 10.2144/000112557

Source DB:  PubMed          Journal:  Biotechniques        ISSN: 0736-6205            Impact factor:   1.993


  7 in total

1.  A new chemotaxis device for cell migration studies.

Authors:  Waseem Khan Raja; Bojana Gligorijevic; Jeff Wyckoff; John S Condeelis; James Castracane
Journal:  Integr Biol (Camb)       Date:  2010-10-12       Impact factor: 2.192

2.  Development path and current status of the NANIVID: a new device for cancer cell studies.

Authors:  Waseem Khan Raja; Michael R Padgen; James K Williams; Frank B Gertler; Jeffrey B Wyckoff; John S Condeelis; James Castracane
Journal:  J Micro Nanolithogr MEMS MOEMS       Date:  2012-03-29       Impact factor: 1.220

3.  Borrelia burgdorferi Migration Assays for Evaluation of Chemoattractants in Tick Saliva.

Authors:  Mary B Jacobs; Britton J Grasperge; Lara A Doyle-Meyers; Monica E Embers
Journal:  Pathogens       Date:  2022-05-01

4.  Mesenchymal stem cell-derived CCL-9 and CCL-5 promote mammary tumor cell invasion and the activation of matrix metalloproteinases.

Authors:  Muthulekha Swamydas; Krista Ricci; Stephen L Rego; Didier Dréau
Journal:  Cell Adh Migr       Date:  2013-05-24       Impact factor: 3.405

5.  Silencing of the Long Noncoding RNA MYCNOS1 Suppresses Activity of MYCN-Amplified Retinoblastoma Without RB1 Mutation.

Authors:  Duangporn Saengwimol; Pamorn Chittavanich; Natanan Laosillapacharoen; Atthapol Srimongkol; Vijender Chaitankar; Duangnate Rojanaporn; Rangsima Aroonroch; Bhoom Suktitipat; Chonticha Saisawang; Saovaros Svasti; Suradej Hongeng; Rossukon Kaewkhaw
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-12-01       Impact factor: 4.799

6.  In silico analysis and in planta production of recombinant ccl21/IL1β protein and characterization of its in vitro anti-tumor and immunogenic activity.

Authors:  Hasan Marashi; Maria Beihaghi; Masoud Chaboksavar; Samad Khaksar; Homan Tehrani; Ardavan Abiri
Journal:  PLoS One       Date:  2022-08-29       Impact factor: 3.752

7.  SDF-1alpha concentration dependent modulation of RhoA and Rac1 modifies breast cancer and stromal cells interaction.

Authors:  Jennifer Pasquier; Nadine Abu-Kaoud; Houari Abdesselem; Aisha Madani; Jessica Hoarau-Véchot; Hamda Al Thawadi; Fabien Vidal; Bettina Couderc; Gilles Favre; Arash Rafii
Journal:  BMC Cancer       Date:  2015-08-01       Impact factor: 4.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.